Regulatory Class: ℞

Generic Name: Eicosapentaenoic acid ethyl ester, Docosahexaenoic acid ethyl ester

Formulations: Eicosapentaenoic acid ethyl ester 460mg, Docosahexaenoic acid ethyl ester 380mg

Indications or Uses Isolated or predominant endogenous hypertriglyceridemia in patient at risk of ischemic heart disease &/or pancreatitis. Supplement to diet when appropriate & assiduous dietary measures alone are insufficient to produce an adequate response.

Dosage and Directions for Use: Hypertriglyceridemia Initially 2 cap daily may be increased to 4 cap daily

Administration: Take w/ food to avoid gastro intestinal disturbances (GI).

Contraindication: Hypersensitivity to Eicosapentaenoic acid (EPA) or Docosahexaenoic (DHA), soya (soya milk, soya beans).

Special Precaution: Thromboxane A2 production may fall during treatment. Monitor patients receiving anticoagulant or other drugs affecting coagulation (eg, ASA, warfarin & coumarin). Routine monitoring of the entire lipid profile; LDL-C especially in patients w/ type IV & V dyslipidemia. Not recommended as monotherapy in type IIb dyslipidemia. Regular monitoring of hepatic function (especially ALT) in patients w/ hepatic impairment. Pregnancy & lactation. Not recommended in childn

Adverse Reaction: Dyspepsia, nausea. Post Myocardial Infarction (MI): gastro intestinal disturbances (GI) disturbances. Hypertriglyceridemia: Eructation taste perversion

Interactions: Increased bleeding time w/ acetylsalicylic acid; warfarin & coumarin.

Presentation/Packaging: Softgel cap 28's.

For more details please see full product information